Masaki Kato
Masaki Kato
Associate Professor, Department of Neuropsychiatry, Kansai Medical University
Verified email at
Cited by
Cited by
Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients
A Serretti, M Kato, D De Ronchi, T Kinoshita
Molecular psychiatry 12 (3), 247-257, 2007
Review and meta-analysis of antidepressant pharmacogenetic findings in major depressive disorder
M Kato, A Serretti
Molecular psychiatry 15 (5), 473-500, 2010
ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder
M Kato, T Fukuda, A Serretti, M Wakeno, G Okugawa, Y Ikenaga, Y Hosoi, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (2), 398-404, 2008
Effects of the serotonin type 2A, 3A and 3B receptor and the serotonin transporter genes on paroxetine and fluvoxamine efficacy and adverse drug reactions in depressed Japanese …
M Kato, T Fukuda, M Wakeno, K Fukuda, G Okugawa, Y Ikenaga, ...
Neuropsychobiology 53 (4), 186-195, 2006
The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response
JM Biernacka, K Sangkuhl, G Jenkins, RM Whaley, P Barman, A Batzler, ...
Translational psychiatry 5 (4), e553-e553, 2015
Effect of 5‐HT1A gene polymorphisms on antidepressant response in major depressive disorder
M Kato, T Fukuda, M Wakeno, G Okugawa, Y Takekita, S Watanabe, ...
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150 …, 2009
Controlled clinical comparison of paroxetine and fluvoxamine considering the serotonin transporter promoter polymorphism
M Kato, Y Ikenaga, M Wakeno, G Okugawa, K Nobuhara, T Fukuda, ...
International clinical psychopharmacology 20 (3), 151-156, 2005
Pharmacogenetic studies in depression: a proposal for methodologic guidelines
A Serretti, M Kato, JL Kennedy
The pharmacogenomics journal 8 (2), 90-100, 2008
Second-generation antipsychotics in the treatment of major depressive disorder: current evidence
C Han, SM Wang, M Kato, SJ Lee, AA Patkar, PS Masand, CU Pae
Expert review of neurotherapeutics 13 (7), 851-870, 2013
Differences in quantitative EEG between frontotemporal dementia and Alzheimer’s disease as revealed by LORETA
K Nishida, M Yoshimura, T Isotani, T Yoshida, Y Kitaura, A Saito, H Mii, ...
Clinical Neurophysiology 122 (9), 1718-1725, 2011
Augmentation treatments with second-generation antipsychotics to antidepressants in treatment-resistant depression
M Kato, CM Chang
CNS drugs 27 (1), 11-19, 2013
Estimated cognitive decline in patients with schizophrenia: A multicenter study
H Fujino, C Sumiyoshi, Y Yasuda, H Yamamori, M Fujimoto, M Fukunaga, ...
Psychiatry and clinical neurosciences 71 (5), 294-300, 2017
The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depression
Y Kageyama, T Kasahara, M Kato, S Sakai, Y Deguchi, M Tani, K Kuroda, ...
Journal of affective disorders 233, 15-20, 2018
Discontinuation of antidepressants after remission with antidepressant medication in major depressive disorder: a systematic review and meta-analysis
M Kato, H Hori, T Inoue, J Iga, M Iwata, T Inagaki, K Shinohara, H Imai, ...
Molecular psychiatry 26 (1), 118-133, 2021
Association of HLA-A* 31: 01 screening with the incidence of carbamazepine-induced cutaneous adverse reactions in a Japanese population
T Mushiroda, Y Takahashi, T Onuma, Y Yamamoto, T Kamei, T Hoshida, ...
JAMA neurology 75 (7), 842-849, 2018
The alpha 2A-adrenergic receptor gene polymorphism modifies antidepressant responses to milnacipran
M Wakeno, M Kato, G Okugawa, T Fukuda, Y Hosoi, Y Takekita, ...
Journal of clinical psychopharmacology 28 (5), 518-524, 2008
Antidepressant response and intolerance to SSRI is not influenced by G-protein β3 subunit gene C825T polymorphism in Japanese major depressive patients
M Kato, M Wakeno, G Okugawa, T Fukuda, Y Takekita, Y Hosoi, J Azuma, ...
Progress in Neuro-Psychopharmacology and Biological Psychiatry 32 (4), 1041-1044, 2008
The serotonin transporter gene and effectiveness of SSRIs
A Serretti, M Kato
Expert Review of Neurotherapeutics 8 (1), 111-120, 2008
No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression
M Kato, M Wakeno, G Okugawa, T Fukuda, J Azuma, T Kinoshita, ...
Neuropsychobiology 56 (4), 167-171, 2007
5-HT2A gene variants influence specific and different aspects of antidepressant response in Japanese and Italian mood disorder patients
M Kato, R Zanardi, D Rossini, D De Ronchi, G Okugawa, T Kinoshita, ...
Psychiatry research 167 (1-2), 97-105, 2009
The system can't perform the operation now. Try again later.
Articles 1–20